Pramiset 0.75 Tablet contains Pramipexole 0.75mg, a dopamine agonist used in the management of Parkinson’s disease and Restless Leg Syndrome (RLS). It helps restore dopamine levels in the brain, improving motor function, reducing tremors, stiffness, and enhancing overall mobility.
Belonging to the Neurology and CNS segment, Pramipexole is a key medication for both early and advanced-stage Parkinson’s treatment. It is widely prescribed by neurologists and movement disorder specialists.
The tablet also provides relief for patients suffering from RLS, reducing uncomfortable sensations and improving sleep quality. Its efficacy and long-term safety profile make it a preferred choice in chronic neurological care.
For PCD pharma franchise partners, distributors, and exporters, Pramiset 0.75 Tablet offers a high-demand, profitable opportunity. It is available for private-label branding, bulk supply, institutional distribution, third-party manufacturing, and export orders across India, ensuring consistent market demand.